| Official name: | State of Eritrea |
|---|---|
| WRLFMD code: | ERI |
| FMD first recorded: | |
| FMD eradicated: | |
| Subsequent outbreaks: | |
| Serotypes (last rpt): | |
| Current status: | Endemic |
| Useful websites: |
| FMDV Serotype | Years (not comprehensive) |
|---|---|
| Untyped | 2005-2009, 2015, 2017-2019 |
| O | 1996, 2004, 2011, 2017 |
| A | 1997-1998, 2006-2009, 2018 |
| C | - |
| Asia 1 | - |
| SAT 1 | - |
| SAT 2 | 2019 |
| SAT 3 | - |
| Notes | prior to 1993 Eritrea was part of Ethiopia |
| WRLFMD batch no. |
Date Received |
Type | Virus samples |
Topotype | Lineage | Sublineage | WRLFMD Reports |
|---|---|---|---|---|---|---|---|
| WRLFMD/2004/00032 | 15/12/2004 | O O O O O NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD |
ERI/1/2004 ERI/2/2004 ERI/3/2004 ERI/21/2004 ERI/22/2004 ERI/4/2004 ERI/5/2004 ERI/6/2004 ERI/7/2004 ERI/8/2004 ERI/9/2004 ERI/10/2004 ERI/11/2004 ERI/12/2004 ERI/13/2004 ERI/14/2004 ERI/15/2004 ERI/16/2004 ERI/17/2004 ERI/18/2004 ERI/19/2004 ERI/20/2004 ERI/23/2004 ERI/24/2004 ERI/25/2004 ERI/26/2004 ERI/27/2004 ERI/28/2004 ERI/29/2004 ERI/30/2004 ERI/31/2004 |
EA-3 EA-3 EA-3 EA-3 EA-3 |
- - - - - |
- - - - - |
Detection Genotyping(O) |
| WRLFMD/2010/00002 | 20/01/2010 | A A A A A A A FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD |
ERI/1/2006 ERI/5/2006 ERI/4/2007 ERI/1/2008 ERI/5/2008 ERI/16/2009 ERI/40/2009 ERI/1/2005 ERI/2/2006 ERI/3/2006 ERI/4/2006 ERI/6/2006 ERI/2/2007 ERI/3/2007 ERI/5/2007 ERI/7/2007 ERI/8/2007 ERI/2/2008 ERI/4/2008 ERI/1/2009 ERI/2/2009 ERI/3/2009 ERI/4/2009 ERI/5/2009 ERI/6/2009 ERI/7/2009 ERI/8/2009 ERI/17/2009 ERI/29/2009 ERI/30/2009 ERI/31/2009 ERI/32/2009 ERI/33/2009 ERI/34/2009 ERI/66/2009 ERI/67/2009 ERI/1/2007 ERI/6/2007 ERI/3/2008 ERI/9/2009 ERI/10/2009 ERI/11/2009 ERI/12/2009 ERI/13/2009 ERI/14/2009 ERI/15/2009 ERI/18/2009 ERI/19/2009 ERI/20/2009 ERI/21/2009 ERI/22/2009 ERI/23/2009 ERI/24/2009 ERI/25/2009 ERI/26/2009 ERI/27/2009 ERI/28/2009 ERI/35/2009 ERI/36/2009 ERI/37/2009 ERI/38/2009 ERI/39/2009 ERI/41/2009 ERI/42/2009 ERI/43/2009 ERI/44/2009 ERI/45/2009 ERI/46/2009 ERI/47/2009 ERI/48/2009 ERI/49/2009 ERI/50/2009 ERI/51/2009 ERI/52/2009 ERI/53/2009 ERI/54/2009 ERI/55/2009 ERI/56/2009 ERI/57/2009 ERI/58/2009 ERI/59/2009 ERI/60/2009 ERI/61/2009 ERI/62/2009 ERI/63/2009 ERI/64/2009 ERI/65/2009 ERI/68/2009 ERI/69/2009 |
AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd |
G-IV G-IV G-IV G-IV G-IV G-IV G-IV nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd nd |
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Detection Genotyping(A) Vaccine |
| WRLFMD/2012/00029 | 01/08/2012 | O O O O O O O O O O O O O O O FMDV‑GD NVD NVD |
ERI/1/2011 ERI/2/2011 ERI/3/2011 ERI/4/2011 ERI/8/2011 ERI/9/2011* ERI/10/2011 ERI/11/2011 ERI/12/2011 ERI/13/2011 ERI/14/2011 ERI/15/2011 ERI/16/2011 ERI/17/2011 ERI/18/2011 ERI/7/2011 ERI/5/2011 ERI/6/2011 |
EA-3 EA-3 EA-3 EA-3 EA-3 nd EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 nd |
unnamed unnamed unnamed unnamed unnamed nd unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed nd |
- - - - - - - - - - - - - - - - |
Detection Genotyping (O) |
| WRLFMD/2019/00031 | 18/12/2019 | O O O O O O A SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD NVD NVD NVD NVD NVD NVD NVD NVD NVD |
ERI/1/2017 ERI/2/2017 ERI/3/2017 ERI/4/2017 ERI/7/2017 ERI/8/2017 ERI/7/2018 ERI/1/2019 ERI/2/2019 ERI/5/2019 ERI/6/2019 ERI/11/2019 ERI/12/2019 ERI/13/2019 ERI/15/2019 ERI/16/2019 ERI/17/2019 ERI/18/2019 ERI/19/2019 ERI/20/2019 ERI/28/2019 ERI/29/2019 ERI/2/2015 ERI/5/2017 ERI/6/2017 ERI/1/2018 ERI/2/2018 ERI/3/2018 ERI/5/2018 ERI/6/2018 ERI/3/2019 ERI/4/2019 ERI/7/2019 ERI/14/2019 ERI/21/2019 ERI/22/2019 ERI/26/2019 ERI/30/2019 ERI/1/2015 ERI/4/2018 ERI/8/2019 ERI/9/2019 ERI/10/2019 ERI/23/2019 ERI/24/2019 ERI/25/2019 ERI/27/2019 |
EA‑3 EA‑3 EA‑3 EA‑3 EA‑3 EA‑3 AFRICA VII VII VII VII VII VII VII VII VII VII VII VII VII VII VII ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ |
‑ ‑ ‑ ‑ ‑ ‑ G‑IV Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 Lib‑12 ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ |
‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ |
Detection Genotyping(O) Genotyping(A) Genotyping(SAT 2) Vaccine |
Notes:
nd, not done
*, no virus isolated in cell cultures